Doxorubicin + Trabectedin Tied to Increased Survival in Metastatic Leiomyosarcoma
Improved overall and progression-free survival seen with combo versus doxorubicin alone for metastatic or unresectable leiomyosarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.